@article{e8a70a7528044edaa8799ef94867adb1,
title = "B-cell lymphomas, version 3.2019: Featured updates to the NCCN Guidelines",
abstract = "Diffuse large B-cell lymphomas (DLBCLs) and follicular lymphoma (FL) are the most common subtypes of B-cell non-Hodgkin's lymphomas in adults. Histologic transformation of FL to DLBCL (TFL) occurs in approximately 15% of patients and is generally associated with a poor clinical outcome. Phosphatidylinositol 3-kinase (PI3K) inhibitors have shown promising results in the treatment of relapsed/refractory FL. CAR T-cell therapy (axicabtagene ciloleucel and tisagenlecleucel) has emerged as a novel treatment option for relapsed/refractory DLBCL and TFL. These NCCN Guidelines Insights highlight important updates to the NCCN Guidelines for B-Cell Lymphomas regarding the treatment of TFL and relapsed/refractory FL and DLBCL.",
author = "Zelenetz, {Andrew D.} and Gordon, {Leo I.} and Abramson, {Jeremy S.} and Advani, {Ranjana H.} and Bartlett, {Nancy L.} and Caimi, {Paolo F.} and Chang, {Julie E.} and Chavez, {Julio C.} and Beth Christian and Fayad, {Luis E.} and Glenn, {Martha J.} and Habermann, {Thomas M.} and Harris, {Nancy Lee} and Francisco Hernandez-Ilizaliturri and Kaminski, {Mark S.} and Kelsey, {Christopher R.} and Nadia Khan and Susan Krivacic and LaCasce, {Ann S.} and Amitkumar Mehta and Auayporn Nademanee and Rachel Rabinovitch and Nishitha Reddy and Erin Reid and Roberts, {Kenneth B.} and Smith, {Stephen D.} and Snyder, {Erin D.} and Swinnen, {Lode J.} and VoseA, {Julie M.} and Dwyer, {Mary A.} and Hema Sundar",
note = "Funding Information: This activity is supported by educational grants from AstraZeneca, Celgene Corporation, Clovis Oncology, Eisai, Genentech, Genomic Health, Inc., Novartis, Taiho Oncology, Inc., and TESARO. This activity is supported by an independent educational grant from AbbVie. This activity is supported by educational funding provided by Amgen. This activity is supported by an unrestricted educational grant from Gilead Sciences, Medical Affairs. Publisher Copyright: {\textcopyright} 2019 Harborside Press. All rights reserved.",
year = "2019",
doi = "10.6004/jnccn.2019.0029",
language = "English",
volume = "17",
pages = "650--661",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
number = "6",
}